Skip to main content

Day: September 13, 2021

Day One Appoints Jaa Roberson as Chief People Officer

SOUTH SAN FRANCISCO, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically-defined cancers, today announced the appointment of Jaa Roberson as chief people officer. In her role, Ms. Roberson will oversee all aspects of Day One’s human resources and talent acquisition efforts. “Day One is built on a foundation of talented employees who share a strong commitment and passion for developing innovative targeted therapies to improve the lives of children and people of all ages living with cancer,” said Jeremy Bender, Ph.D., chief executive officer of Day One. “We could not be more excited to welcome Jaa to our senior leadership team. As the Company continues...

Continue reading

LMP Announces a Definitive Acquisition Agreement to Purchase an 85% Interest in the Alan Jay Automotive Network, a 12-Dealership Group in Florida, Along with the Associated Real Estate, Generating Approximately $345 Million in Annualized Re

FORT LAUDERDALE, FL , Sept. 13, 2021 (GLOBE NEWSWIRE) — LMP Automotive Holdings, Inc. (NASDAQ: LMPX), an e-commerce and facilities-based automotive retailer in the United States, today announced its entry into definitive acquisition agreements to purchase an 85% interest in the Alan Jay Automotive Network, a 12-dealership group in Florida, along with the associated real estate, generating approximately $345 million in annualized revenue and $18.3 million in adjusted EBITDA.Expected to close in the fourth quarter of this year. Aggregate Purchase price of approximately $50 million for goodwill expected to be funded through a combination of cash on LMP’s balance sheet, up to $25 million in common stock and debt financing. Aggregate Real estate purchase price of approximately $44.1 million.Expected to add approximately $18.3...

Continue reading

Jushi Holdings Inc. Completes Nature’s Remedy Acquisition and Officially Enters Massachusetts Market

Jushi Holdings Inc. Completes Acquisition of Massachusetts-Based Nature’s RemedyNegotiates Revised Transaction Terms Resulting in 4.3 million Fewer Shares Issued Adds Vertically Integrated Operator with Two Retail Dispensaries and a Cultivation and Manufacturing Facility Officially Enters Its Seventh State and Expands Retail Footprint to 24 Dispensaries NationwideBOCA RATON, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator announced it has closed its previously announced acquisition of Nature’s Remedy of Massachusetts, Inc. and certain of its affiliates (collectively, “Nature’s Remedy”), a vertically integrated, single-state operator in Massachusetts, for total upfront consideration of US$91.2 million (the...

Continue reading

TCR2 Therapeutics to Announce Extended Results from Ongoing Phase 1/2 Trial of Gavo-cel in Mesothelin-Expressing Solid Tumors

CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that the Company will host a conference call and live audio webcast on Friday, September 17, 2021 at 9:00am E.T. to discuss extended data from the ongoing Phase 1 portion of the gavo-cel Phase 1/2 clinical trial for mesothelin-expressing solid tumors. The dataset will be an extension of the oral presentation at the European Society for Medical Oncology (ESMO) Congress 2021 on September 17 at 14:20 CEST (8:20am ET) (Presentation #959O) that is part of the official ESMO Press Programme. The Company presentation will include clinical and translational data from at least 17 evaluable patients with gavo-cel up to...

Continue reading

Solar Tracker Market to rise at CAGR of 18% through 2028 – Report by Market Research Future (MRFR)

New York, Sept. 13, 2021 (GLOBE NEWSWIRE) — Solar PV Tracker Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Solar PV Tracker Market Research Report, Type, Tracking type, Drive system, End-User and Region – Forecast till 2028” the market to grow at 18% CAGR from 2021 to 2028 (forecast period). Key Players List of the Notable players of the global solar PV tracker market are –Convert Italia (Italy) Arctech Solar (India) Exosun (U.S.) Ideematec (Germany) First Solar (U.S.) Grupo Clavijo (Spain) Mahindra Susten (India) NClave (Spain) NEXTracker (U.S.) Scorpius Trackers (India) Solar Steel (Spain) Soltec(U.S.) STi Norland (Spain) PV Hardware (U.S.) Sun Action Trackers (U.S.) SunLink (U.S.) SunPower (U.S.).Get Free Sample PDF Brochure https://www.marketresearchfuture.com/sample_request/5874 Increased...

Continue reading

Eden Empire Announces New Director in Expansion Push

VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “Eden Empire” or “EDEN™”) is pleased to announce that Philip van den Berg has joined the Company’s board of directors and will act as Chairman of the Audit Committee. Key Takeaways:Mr. van den Berg brings 35+ years of investment banking expertise. Co-founder of Taler Asset Management and is an acting director of Halo Collective (OTCMKTS: HCANF). Previously an executive director for Goldman Sachs.Philip van den Berg (1958): graduated cum laude in economics in 1985 at the University of Amsterdam. After graduating Mr. van den Berg joined Pierson, Heldring & Pierson in the Netherlands as an investment analyst. Most of his experience on the sell side was with Goldman Sachs in London where he...

Continue reading

MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology

Phase 2B Knee Osteoarthritis (KOA) Study Top-line Interim Results Demonstrate Varied Efficacy Signals between Patient Cohorts Company to Pursue Phase 3 KOA Confirmatory Studies Initial Review of Phase 3 Plantar Fasciitis Trial Data Does Not Support a Biologics License Application (BLA) Filing at This Time, Pending Further Analysis MARIETTA, Ga., Sept. 13, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced top-line results from two late-stage musculoskeletal clinical trials of the Company’s micronized dehydrated Human Amnion Chorion Membrane (mdHACM): a Phase 2B clinical trial for the treatment of Knee Osteoarthritis (KOA) and a Phase 3 clinical trial for the treatment of Plantar Fasciitis...

Continue reading

Paya Holdings Inc. Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants

ATLANTA, Sept. 13, 2021 (GLOBE NEWSWIRE) — Paya Holdings Inc. (NASDAQ: PAYA) (“Paya” or the “Company”) announced today the expiration and results of its previously announced exchange offer (the “Exchange Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding warrants to purchase shares of common stock, par value $0.001 per share, of the Company. The Exchange Offer and Consent Solicitation expired at 11:59 p.m., Eastern Daylight Time, on September 10, 2021. Paya has been advised that 17,380,396 public warrants (including 209,726 public warrants tendered through guaranteed delivery), or approximately 98.4% of the outstanding public warrants, and 50,000 private warrants, representing all outstanding private warrants, were validly tendered and not validly withdrawn prior to the expiration of the Exchange...

Continue reading

Harju Elekter to restructure its operations and establish new plants in Sweden

Harju Elekter has decided to centralise production in Sweden by moving the various units of the Swedish subsidiary to Västerås and Malmö, as well as establish new plants in these locations in order to expand its business activities. As a result of the decision, Harju Elekter AB signed a letter of intent and a lease agreement today, on 13 September, for the establishment of an office and production building in Västerås and for a new production building to be constructed in Malmö, respectively. In order to lease the 3,000 m2 building in Malmö, which will be completed by the end of 2022, a ten-year lease agreement was entered into with Nyfosa AB. For the purpose of establishing the 6,000 m2 building in Västerås, a letter of intent was signed to purchase LC Development Fastigheter 17 AB, currently a wholly owned subsidiary of Wästbygg Gruppen...

Continue reading

Brunswick Corporation to Present at CL King’s 19th Annual Best Ideas Conference 2021

METTAWA, Ill., Sept. 13, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) Chief Executive Officer David M. Foulkes, Executive Vice President & CFO Ryan Gwillim, and Vice President of Investor Relations Brent Dahl will present virtually at CL King’s 19th Annual Best Ideas Conference on Tuesday, September 14, 2021 at 3:15 PM Central Time. The presentation will be webcast live and can be accessed by clicking on the following link, https://wsw.com/webcast/clk21/bc/1354897 or by copying and pasting the link into a web-browser. The presentation can also be accessed through the Investor page on the Brunswick website. Following the webcast, an archived replay will be available on the company’s website using the aforementioned links. About Brunswick Headquartered in Mettawa, Ill., Brunswick Corporation’s leading consumer brands...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.